Saoirse O'Sullivan
Saoirse O'Sullivan
No verified email
Cited by
Cited by
Cannabinoids go nuclear: evidence for activation of peroxisome proliferator‐activated receptors
SE O'sullivan
British journal of pharmacology 152 (5), 576-582, 2007
Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease
SE O'sullivan, DA Kendall
Immunobiology 215 (8), 611-616, 2010
An update on PPAR activation by cannabinoids
SE O'Sullivan
British journal of pharmacology 173 (12), 1899-1910, 2016
A systematic review on the pharmacokinetics of cannabidiol in humans
SA Millar, NL Stone, AS Yates, SE O'sullivan
Frontiers in pharmacology 9, 1365, 2018
The complexities of the cardiovascular actions of cannabinoids
MD Randall, DA Kendall, S O'Sullivan
British journal of pharmacology 142 (1), 20-26, 2004
The effects of exercise and training on human cardiovascular reflex control
SE O’Sullivan, C Bell
Journal of the autonomic nervous system 81 (1-3), 16-24, 2000
Time-dependent vascular actions of cannabidiol in the rat aorta
SE O'Sullivan, Y Sun, AJ Bennett, MD Randall, DA Kendall
European journal of pharmacology 612 (1-3), 61-68, 2009
Novel time-dependent vascular actions of Δ9-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma
SE O’Sullivan, EJ Tarling, AJ Bennett, DA Kendall, MD Randall
Biochemical and biophysical research communications 337 (3), 824-831, 2005
Efficacy and safety of cannabidiol and tetrahydrocannabivarin on glycemic and lipid parameters in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled …
KA Jadoon, SH Ratcliffe, DA Barrett, EL Thomas, C Stott, JD Bell, ...
Diabetes Care 39 (10), 1777-1786, 2016
Cannabidiol protects an in vitro model of the blood–brain barrier from oxygen‐glucose deprivation via PPARγ and 5‐HT1A receptors
WH Hind, TJ England, SE O'Sullivan
British journal of pharmacology 173 (5), 815-825, 2016
Cannabinoids mediate opposing effects on inflammation‐induced intestinal permeability
A Alhamoruni, KL Wright, M Larvin, SE O'sullivan
British journal of pharmacology 165 (8), 2598-2610, 2012
RECAST (remote ischemic conditioning after stroke trial) a pilot randomized placebo controlled phase II trial in acute ischemic stroke
TJ England, A Hedstrom, S O’Sullivan, R Donnelly, DA Barrett, S Sarmad, ...
Stroke 48 (5), 1412-1415, 2017
Vascular targets for cannabinoids: animal and human studies
C Stanley, SE O'Sullivan
British Journal of Pharmacology 171 (6), 1361-1378, 2014
Is the cardiovascular system a therapeutic target for cannabidiol?
CP Stanley, WH Hind, SE O'Sullivan
British journal of clinical pharmacology 75 (2), 313-322, 2013
A systematic review of cannabidiol dosing in clinical populations
SA Millar, NL Stone, ZD Bellman, AS Yates, TJ England, SE O'Sullivan
British journal of clinical pharmacology 85 (9), 1888-1900, 2019
Pharmacological effects of cannabinoids on the Caco-2 cell culture model of intestinal permeability
A Alhamoruni, AC Lee, KL Wright, M Larvin, SE O'Sullivan
Journal of Pharmacology and Experimental Therapeutics 335 (1), 92-102, 2010
Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries
SE O'Sullivan, DA Kendall, MD Randall
British journal of pharmacology 142 (3), 435-442, 2004
Cannabinoids in experimental stroke: a systematic review and meta-analysis
TJ England, WH Hind, NA Rasid, SE O'sullivan
Journal of Cerebral Blood Flow & Metabolism 35 (3), 348-358, 2015
Endocannabinoids modulate human blood–brain barrier permeability in vitro
WH Hind, C Tufarelli, M Neophytou, SI Anderson, TJ England, ...
British journal of pharmacology 172 (12), 3015-3027, 2015
A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study
KA Jadoon, GD Tan, SE O’Sullivan
JCI insight 2 (12), 2017
The system can't perform the operation now. Try again later.
Articles 1–20